Filter News
Area of Research
- (-) Advanced Manufacturing (2)
- (-) Nuclear Science and Technology (4)
- Biology and Environment (9)
- Clean Energy (44)
- Computer Science (3)
- Electricity and Smart Grid (1)
- Fusion and Fission (2)
- Isotopes (9)
- Materials (39)
- Materials for Computing (9)
- National Security (12)
- Neutron Science (3)
- Quantum information Science (2)
- Sensors and Controls (1)
- Supercomputing (15)
News Topics
- (-) Cybersecurity (1)
- (-) Isotopes (3)
- (-) Transformational Challenge Reactor (2)
- 3-D Printing/Advanced Manufacturing (19)
- Advanced Reactors (7)
- Artificial Intelligence (1)
- Bioenergy (2)
- Biomedical (2)
- Composites (3)
- Computer Science (2)
- Decarbonization (1)
- Fusion (3)
- Machine Learning (1)
- Materials (4)
- Materials Science (5)
- Molten Salt (3)
- Neutron Science (3)
- Nuclear Energy (18)
- Physics (1)
- Space Exploration (5)
- Sustainable Energy (6)
Media Contacts
Oak Ridge National Laboratory researchers have developed artificial intelligence software for powder bed 3D printers that assesses the quality of parts in real time, without the need for expensive characterization equipment.
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
Researchers at the Department of Energy’s Oak Ridge National Laboratory are refining their design of a 3D-printed nuclear reactor core, scaling up the additive manufacturing process necessary to build it, and developing methods
Researchers at the Department of Energy’s Oak Ridge National Laboratory have received five 2019 R&D 100 Awards, increasing the lab’s total to 221 since the award’s inception in 1963.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.